Evidence of microvascular dysfunction in patients with cystic fibrosis

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 11, 2016, Pages H1479-H1485

  Rodriguez Miguelez, Paula ^a   Thomas, Jeffrey ^a   Seigler, Nichole ^a   Crandall, Reva ^a   McKie, Kathleen T ^a   Forseen, Caralee ^a   Harris, Ryan A ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Cystic fibrosis; Endothelial function; Endothelium dependent vasodilation; Microvascular function

Indexed keywords

ACETYLCHOLINE; VASODILATOR AGENT;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; EXERCISE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPEREMIA; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; LOCAL THERMAL HYPEREMIA; LUNG DISEASE; LUNG FUNCTION TEST; MALE; MICROANGIOPATHY; POSTOCCLUSIVE REACTIVE HYPEREMIA; PRIORITY JOURNAL; VASODILATATION; YOUNG ADULT; ADOLESCENT; BLOOD FLOW; BLOOD FLOW VELOCITY; CASE CONTROL STUDY; CUTANEOUS DRUG ADMINISTRATION; DRUG EFFECTS; EXERCISE TOLERANCE; FOREARM; LUNG; MICROCIRCULATION; MICROVASCULATURE; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VASCULARIZATION; VITAL CAPACITY;

ACETYLCHOLINE; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FOREARM; HUMANS; HYPEREMIA; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; LUNG; MALE; MICROCIRCULATION; MICROVESSELS; REGIONAL BLOOD FLOW; SEVERITY OF ILLNESS INDEX; VASODILATION; VASODILATOR AGENTS; VITAL CAPACITY; YOUNG ADULT;

EID: 84983783881     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00136.2016     Document Type: Article

References (58)

1. Abraham EH, Sterling KM, Kim RJ, Salikhova AY, Huffman HB, Crockett MA, Johnston N, Parker HW, Boyle WE Jr, Hartov A, Demidenko E, Efird J, Kahn J, Grubman SA, Jefferson DM, Robson SC, Thakar JH, Lorico A, Rappa G, Sartorelli AC, Okunieff P. Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol Dis 27: 165–180, 2001.
2. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription (6th ed.). Philadelphia, PA: Lippincott Williams and Wilkins, 2005.
3. Antus B. Oxidative stress markers in sputum. Oxid Med Cell Longev 2016: 2930434, 2016.
4. Ashor AW, Lara J, Siervo M, Celis-Morales C, Oggioni C, Jakovljevic DG, Mathers JC. Exercise modalities and endothelial function: a sys-tematic review and dose-response meta-analysis of randomized controlled trials. Sports Med 45: 279–296, 2015.
5. Braga VA, Couto GK, Lazzarin MC, Rossoni LV, Medeiros A. Aerobic exercise training prevents the onset of endothelial dysfunction via increased nitric oxide bioavailability and reduced reactive oxygen species in an experimental model of menopause. PLos One 10: e0125388, 2015.
6. Brown RK, Wyatt H, Price JF, Kelly FJ. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 9: 334–339, 1996.
7. Bruning RS, Santhanam L, Stanhewicz AE, Smith CJ, Berkowitz DE, Kenney WL, Holowatz LA. Endothelial nitric oxide synthase mediates cutaneous vasodilation during local heating and is attenuated in middle-aged human skin. J Appl Physiol 112: 2019–2026, 2012.
8. Brunt VE, Minson CT. Cutaneous thermal hyperemia: more than skin deep. J Appl Physiol 111: 5–7, 2011.
9. Buus NH, Simonsen U, Pilegaard HK, Mulvany MJ. Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol 129: 184–192, 2000.
10. Clarkson P, Montgomery HE, Mullen MJ, Donald AE, Powe AJ, Bull T, Jubb M, World M, Deanfield JE. Exercise training enhances endo-thelial function in young men. J Am Coll Cardiol 33: 1379–1385, 1999.
11. Clayton A, Knox AJ. COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis? Thorax 61: 552–553, 2006.
12. Cracowski JL, Roustit M. Current methods to assess human cutaneous blood flow. An updated focus on laser based-techniques. Microcirculation. In press.
13. Dupont JJ, Farquhar WB, Townsend RR, Edwards DG. Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kid-ney disease. J Appl Physiol 111: 1561–1567, 2011.
14. Fielding J, Brantley L, Seigler N, McKie KT, Davison GW, Harris RA. Oxygen uptake kinetics and exercise capacity in children with cystic fibrosis. Pediatr Pulmonol 50: 647–654, 2015.
15. Godfrey S. Exercise tests in assessing children with lung or heart disease. Thorax 25: 258, 1970.
16. Harris LW, Wayland M, Lan M, Ryan M, Giger T, Lockstone H, Wuethrich I, Mimmack M, Wang L, Kotter M, Craddock R, Bahn S. The cerebral microvasculature in schizophrenia: a laser capture microdis-section study. PLos One 3: e3964, 2008.
17. Hector A, Griese M, Hartl D. Oxidative stress in cystic fibrosis lung disease: an early event, but worth targeting? Eur Respir J 44: 17–19, 2014.
18. Holowatz LA, Thompson-Torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 105: 370–372, 2008.
19. Keahey TM, Indrisano J, White MV, Kaliner MA. Analyses of micro-vascular permeability in response to mediators of immediate hypersensi-tivity. J Allergy Clin Immunol 87: 586–594, 1991.
20. Kellogg DL Jr, Liu Y, Kosiba IF, O’Donnell D. Role of nitric oxide in the vascular effects of local warming of the skin in humans. J Appl Physiol 86: 1185–1190, 1999.
21. Kellogg DL Jr, Zhao JL, Coey U, Green JV. Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol 98: 629–632, 2005.
22. Larkin SW, Williams TJ. Evidence for sensory nerve involvement in cutaneous reactive hyperemia in humans. Circ Res 73: 147–154, 1993.
23. Lobato NS, Filgueira FP, Akamine EH, Tostes RC, Carvalho MH, Fortes ZB. Mechanisms of endothelial dysfunction in obesity-associated hypertension. Braz J Med Biol Res 45: 392–400, 2012.
24. Lorenzo S, Minson CT. Human cutaneous reactive hyperaemia: role of BK Ca channels and sensory nerves. J Physiol 585: 295–303, 2007.
25. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60: 1455–1469, 2012.
26. Medow MS, Bamji N, Clarke D, Ocon AJ, Stewart JM. Reactive oxygen species (ROS) from NADPH and xanthine oxidase modulate the cutaneous local heating response in healthy humans. J Appl Physiol 111: 20–26, 2011.
27. Minson CT. Thermal provocation to evaluate microvascular reactivity in human skin. J Appl Physiol 109: 1239–1246, 2010.
28. Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 91: 1619–1626, 2001.
29. Moorcroft AJ, Dodd ME, Webb AK. Exercise testing and prognosis in adult cystic fibrosis. Thorax 52: 291–293, 1997.
30. Morris SJ, Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 496: 531–542, 1996.
31. Mullineaux DR, Bartlett RM, Bennett S. Research design and statistics in biomechanics and motor control. J Sports Sci 19: 739–760, 2001.
32. Munzel T, Daiber A, Ullrich V, Mulsch A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expres-sion of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25: 1551–1557, 2005.
33. Newton DJ, Davies J, Belch JJ, Khan F. Role of endothelium-derived hyperpolarising factor in acetylcholine-mediated vasodilatation in skin. Int Angiol 32: 312–318, 2013.
34. Nguyen S, Leroy S, Cracowski C, Perez T, Valette M, Neviere R, Aguilaniu B, Wallaert B. [Prognostic value of clinical exercise testing in adult patients with cystic fibrosis]. Rev Mal Respir 27: 219–225, 2010.
35. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 327: 1785–1788, 1992.
36. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 373: 1891–1904, 2009.
37. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, Trevisan M, Iacoviello L, Cassano PA, Schunemann HJ. Oxidative stress and pulmonary function in the general population. Am J Epidemiol 162: 1137–1145, 2005.
38. Pastre J, Prevotat A, Tardif C, Langlois C, Duhamel A, Wallaert B. Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease. BMC Pulm Med 14: 74, 2014.
39. Poore S, Berry B, Eidson D, McKie KT, Harris RA. Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis. Chest 143: 939–945, 2013.
40. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 40: 1324–1343, 2012.
41. Rasool AH, Abdul Rahman AS, Abd Ghaffar NA, Nik Mahmood NM, Wong AR. Abnormal microvascular reactivity with hypercholesterolae-mia in pregnancy. Malays J Med Sci 17: 14–19, 2010.
42. Reverri EJ, Morrissey BM, Cross CE, Steinberg FM. Inflammation, oxidative stress, and cardiovascular disease risk factors in adults with cystic fibrosis. Free Radic Biol Med 76: 261–277, 2014.
43. Rosenbluth DB, Wilson K, Ferkol T, Schuster DP. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 126: 412–419, 2004.
44. Roustit M, Cracowski JL. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol Sci 34: 373–384, 2013.
45. Roustit M, Cracowski JL. Non-invasive assessment of skin microvas-cular function in humans: an insight into methods. Microcirculation 19: 47–64, 2012.
46. Schunemann HJ, Muti P, Freudenheim JL, Armstrong D, Browne R, Klocke RA, Trevisan M. Oxidative stress and lung function. Am J Epidemiol 146: 939–948, 1997.
47. Strain WD, Chaturvedi N, Bulpitt CJ, Rajkumar C, Shore AC. Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes 54: 1816–1822, 2005.
48. Szewczyk A, Jarmuszkiewicz W, Koziel A, Sobieraj I, Nobik W, Lukasiak A, Skup A, Bednarczyk P, Drabarek B, Dymkowska D, Wrzosek A, Zablocki K. Mitochondrial mechanisms of endothelial dys-function. Pharmacol Rep 67: 704–710, 2015.
49. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 90: 2285–2290, 1994.
50. Tee GB, Rasool AH, Halim AS, Rahman AR. Dependence of human forearm skin postocclusive reactive hyperemia on occlusion time. J Pharmacol Toxicol Methods 50: 73–78, 2004.
51. Tur E, Politi Y, Rubinstein A. Cutaneous blood flow abnormalities in hypertriglyceridemia. J Invest Dermatol 103: 597–600, 1994.
52. Van Iterson EH, Karpen SR, Baker SE, Wheatley CM, Morgan WJ, Snyder EM. Impaired cardiac and peripheral hemodynamic responses to inhaled β2-agonist in cystic fibrosis. Respir Res 16: 103, 2015.
53. Wesley NO, Maibach HI. Racial (ethnic) differences in skin properties: the objective data. Am J Clin Dermatol 4: 843–860, 2003.
54. Wilkins BW, Martin EA, Roberts SK, Joyner MJ. Preserved reflex cutaneous vasodilation in cystic fibrosis does not include an enhanced nitric oxide-dependent mechanism. J Appl Physiol 102: 2301–2306, 2007.
55. Wong BJ, Wilkins BW, Holowatz LA, Minson CT. Nitric oxide syn-thase inhibition does not alter the reactive hyperemic response in the cutaneous circulation. J Appl Physiol 95: 504–510, 2003.
56. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 20: 157–165, 2001.
57. Woodward DF, Nieves AL, Williams LS, Gary RK Jr, Wasserman MA, Gleason JG. Interactive effects of peptidoleukotrienes and histamine on microvascular permeability and their involvement in experimental cutaneous and conjunctival immediate hypersensitivity. Eur J Pharmacol 164: 323–333, 1989.
58. Zhao JL, Pergola PE, Roman LJ, Kellogg DL Jr. Bioactive nitric oxide concentration does not increase during reactive hyperemia in human skin. J Appl Physiol 96: 628–632, 2004.